Search research articles
Contact Us
Filters
Showing results (11-20 of 629) with videos related to
Page
of 63
Sort By:
European Urology
|
April 2, 2017
Re: Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-analysis of 13 140 Patients
Dominik Abt, Hans-Peter Schmid
Oncology and Therapy
|
July 7, 2017
A Review of Fulvestrant in Breast Cancer
Mark R Nathan, Peter Schmid
Urology
|
October 19, 2005
Novel use of fine needle aspiration of seminal vesicles for sperm retrieval in infertile men
Dominik Boehlen, Hans-Peter Schmid
Urology
|
December 8, 2009
Re: Hellstrom WJG, et al.: Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia (BPH) and BPH treatment. (Urology 2009;74:15-21)
Hans-Peter Schmid, Dominik Böhlen
Breast Cancer Research and Treatment
|
March 2, 2022
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
Peter E Hall, Peter Schmid
Expert Opinion on Emerging Drugs
|
April 19, 2021
Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials
Peter E Hall, Peter Schmid
Case Reports in Dermatology
|
January 24, 2013
Treatment of severe cold contact urticaria with omalizumab: case reports
Petra Brodská, Peter Schmid-Grendelmeier
Praxis
|
October 4, 2013
[Urination disorders in the man: differential diagnoses and therapy of benign prostate syndrome]
Daniel Meyer, Hans-Peter Schmid
Urological Research
|
June 28, 2002
The rise and fall of PSA: clinical implications of prostate specific antigen kinetics
Axel Semjonow, Hans-Peter Schmid
Breast (Edinburgh, Scotland)
|
June 7, 2017
The emerging world of breast cancer immunotherapy
Mark R Nathan, Peter Schmid
Page
of 63
Search research articles
Search
Showing results (11-20 of 629) with videos related to
Sort By:
Page
of 63
European Urology
|
April 2, 2017
Re: Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-analysis of 13 140 Patients
Dominik Abt, Hans-Peter Schmid
Oncology and Therapy
|
July 7, 2017
A Review of Fulvestrant in Breast Cancer
Mark R Nathan, Peter Schmid
Urology
|
October 19, 2005
Novel use of fine needle aspiration of seminal vesicles for sperm retrieval in infertile men
Dominik Boehlen, Hans-Peter Schmid
Urology
|
December 8, 2009
Re: Hellstrom WJG, et al.: Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia (BPH) and BPH treatment. (Urology 2009;74:15-21)
Hans-Peter Schmid, Dominik Böhlen
Breast Cancer Research and Treatment
|
March 2, 2022
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
Peter E Hall, Peter Schmid
Expert Opinion on Emerging Drugs
|
April 19, 2021
Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials
Peter E Hall, Peter Schmid
Case Reports in Dermatology
|
January 24, 2013
Treatment of severe cold contact urticaria with omalizumab: case reports
Petra Brodská, Peter Schmid-Grendelmeier
Praxis
|
October 4, 2013
[Urination disorders in the man: differential diagnoses and therapy of benign prostate syndrome]
Daniel Meyer, Hans-Peter Schmid
Urological Research
|
June 28, 2002
The rise and fall of PSA: clinical implications of prostate specific antigen kinetics
Axel Semjonow, Hans-Peter Schmid
Breast (Edinburgh, Scotland)
|
June 7, 2017
The emerging world of breast cancer immunotherapy
Mark R Nathan, Peter Schmid
Page
of 63